0001062993-20-006255.txt : 20201211 0001062993-20-006255.hdr.sgml : 20201211 20201211165329 ACCESSION NUMBER: 0001062993-20-006255 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201209 FILED AS OF DATE: 20201211 DATE AS OF CHANGE: 20201211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boston Megan CENTRAL INDEX KEY: 0001808923 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 201384075 MAIL ADDRESS: STREET 1: LEVEL 14, 114 WILLIAM ST CITY: MELBOURNE, VIC STATE: C3 ZIP: 3000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Benitec Biopharma Inc. CENTRAL INDEX KEY: 0001808898 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: LEVEL 14, 114 WILLIAM ST CITY: MELBOURNE, VIC STATE: C3 ZIP: 3000 BUSINESS PHONE: 61(0)3 8692-7222 MAIL ADDRESS: STREET 1: LEVEL 14, 114 WILLIAM ST CITY: MELBOURNE, VIC STATE: C3 ZIP: 3000 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2020-12-09 0001808898 Benitec Biopharma Inc. BNTC 0001808923 Boston Megan C/O BENITEC BIOPHARMA INC. 3940 TRUST WAY HAYWARD CA 94545 1 1 0 0 Executive Director Options (right to buy) 2.98 2020-12-09 4 A 0 142172 0 A 2030-12-09 Common Stock 142172 142172 D The stock options will vest in three substantially equal installments on December 9, 2021, December 9, 2022, and December 9, 2023. /s/ Megan Boston 2020-12-11